LQDA

Liquidia (LQDA)

Liquidia Corporation

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:LQDA

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/15	05:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LQDA	Liquidia Corporation
2024/05/14	06:43	GlobeNewswire Inc.	Liquidia Corporation Reports First Quarter 2024 Financial Results and Provides Corporate Update	NASDAQ:LQDA	Liquidia Corporation
2024/05/14	06:10	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:LQDA	Liquidia Corporation
2024/05/10	21:00	GlobeNewswire Inc.	Liquidia Announces Poster Presentation at the American Thoracic Society (ATS) 2024 International Conference on Its Open-Label Safety Study of L606 (Liposomal Treprostinil) in Patients with PAH and PH-ILD	NASDAQ:LQDA	Liquidia Corporation
2024/05/07	21:30	GlobeNewswire Inc.	Liquidia Corporation to Present at BofA Securities Health Care Conference 2024	NASDAQ:LQDA	Liquidia Corporation
2024/05/07	21:00	GlobeNewswire Inc.	Liquidia Corporation to Report First Quarter 2024 Financial Results on May 14, 2024	NASDAQ:LQDA	Liquidia Corporation
2024/04/02	22:00	GlobeNewswire Inc.	Liquidia Corporation to Present at 23rd Annual Needham Virtual Healthcare Conference	NASDAQ:LQDA	Liquidia Corporation
2024/04/01	19:00	GlobeNewswire Inc.	Update on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA™ (treprostinil) inhalation powder	NASDAQ:LQDA	Liquidia Corporation
2024/03/13	19:00	GlobeNewswire Inc.	Liquidia Corporation Reports Full Year 2023 Financial Results and Provides Corporate Update	NASDAQ:LQDA	Liquidia Corporation
2024/03/06	20:30	GlobeNewswire Inc.	Liquidia Corporation to Report Full Year 2023 Financial Results on Wednesday, March 13, 2024	NASDAQ:LQDA	Liquidia Corporation
2024/03/05	09:07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LQDA	Liquidia Corporation
2024/01/30	20:30	GlobeNewswire Inc.	Liquidia Corporation Announces Poster Presentation at the Pulmonary Vascular Research Institute 2024 Annual Congress	NASDAQ:LQDA	Liquidia Corporation
2024/01/25	21:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LQDA	Liquidia Corporation
2024/01/25	20:00	GlobeNewswire Inc.	Liquidia Corporation Provides Update on New Drug Application for YUTREPIA™ (treprostinil) inhalation powder	NASDAQ:LQDA	Liquidia Corporation
2024/01/23	21:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LQDA	Liquidia Corporation
2024/01/19	21:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LQDA	Liquidia Corporation
2024/01/19	20:30	GlobeNewswire Inc.	Liquidia Corporation Announces Updates to Operations Leadership	NASDAQ:LQDA	Liquidia Corporation
2024/01/17	07:04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LQDA	Liquidia Corporation
2024/01/17	07:03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LQDA	Liquidia Corporation
2024/01/17	07:02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LQDA	Liquidia Corporation
2024/01/16	21:42	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:LQDA	Liquidia Corporation
2024/01/09	06:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LQDA	Liquidia Corporation
2024/01/08	22:22	GlobeNewswire Inc.	Liquidia Corporation Files Response to United Therapeutics Lawsuit and Files Counterclaims	NASDAQ:LQDA	Liquidia Corporation
2024/01/05	20:45	GlobeNewswire Inc.	Liquidia Provides Update on Clinical Pipeline Targeting PAH and PH-ILD	NASDAQ:LQDA	Liquidia Corporation
2024/01/05	11:37	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LQDA	Liquidia Corporation
2024/01/04	23:10	GlobeNewswire Inc.	Liquidia Corporation Announces $100 Million in New Financings	NASDAQ:LQDA	Liquidia Corporation
2024/01/04	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:LQDA	Liquidia Corporation
2024/01/02	20:45	GlobeNewswire Inc.	Liquidia Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference	NASDAQ:LQDA	Liquidia Corporation
2023/12/29	06:30	Edgar (US Regulatory)	Form S-3/A - Registration statement under Securities Act of 1933: [Amend]	NASDAQ:LQDA	Liquidia Corporation
2023/12/23	06:08	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:LQDA	Liquidia Corporation